Postmenopausal uterine bleeding, defined as any vaginal bleeding occurring at least 12 months after the final menstrual period, is a clinically significant symptom that warrants prompt evaluation. Although most cases are due to benign etiologies, such as genitourinary syndrome of menopause (vaginal or endometrial atrophy), endometrial polyps, or hormone-related changes, postmenopausal uterine bleeding is the presenting symptom in approximately 90% of patients with endometrial cancer. Early detection of endometrial cancer is essential, with the diagnostic approach focusing on ruling out other causes of bleeding, stratifying the patient’s risk, and obtaining tests such as transvaginal ultrasonography or endometrial sampling (biopsy) to rule out malignancy. Management of postmenopausal uterine bleeding is based on the underlying cause and can range from hormone therapy to polypectomy for intracavitary polyps or surgical referral for atypical hyperplasia, endometrial intraepithelial neoplasia, or carcinoma. Postmenopausal bleeding can also lead to significant patient concern and distress, largely due to fear of underlying malignancy. A systematic, evidence-based approach to postmenopausal uterine bleeding evaluation allows clinicians to diagnose serious pathology early and address patient concerns with clear guidance and follow-up treatment plans.
Miller A, Paruchuri B. Menstrual Disorders: Postmenopausal Uterine Bleeding. FP Essent. 2026;570:22-27.
Case 3. ES is a 62-year-old patient with vaginal bleeding that began 2 weeks ago and lasted for 3 days. Her last menstrual period was at age 56 years, and she reports no prior episodes of postmenopausal bleeding. Her medical history includes hypertension and obesity with a body mass index of 37 kg/m2. She does not use hormone therapy. She expresses concern about cancer.
Background and Epidemiology
Postmenopausal bleeding accounts for approximately 5% to 10% of gynecologic visits in individuals older than 55 years.1 It is defined as any vaginal bleeding that occurs at least 12 months after the final menstrual period.1 Although most cases are due to benign etiologies, postmenopausal bleeding warrants prompt evaluation because it can be the presenting symptom of endometrial carcinoma.2 Less than 10% of cases of postmenopausal bleeding are due to cancer, but approximately 90% of patients with an endometrial cancer diagnosis report having postmenopausal bleeding.2
Beyond the medical implications, postmenopausal bleeding is often associated with significant patient concern and distress, largely due to fear of underlying malignancy. These concerns may contribute to delays in seeking care, particularly among patients with limited access to gynecologic services or irregular engagement with preventive care.2
Differential Diagnosis
The most common etiology of postmenopausal bleeding is genitourinary syndrome of menopause (vaginal or endometrial atrophy), followed by endometrial polyps, endometrial hyperplasia, and endometrial carcinoma1,3 (Table 11–7). Less common causes include cervical neoplasia, hormone therapy–related bleeding, and rarely ovarian tumors.1,3 Nongynecologic mimics should also be considered. They include hematuria from urologic pathology, rectal bleeding from gastrointestinal sources, and vulvar bleeding from dermatologic conditions such as lichen sclerosus.1,5
Table 1. Common Etiologies of Postmenopausal Bleeding
| Etiology | Typical presentation | Clinical features | Management |
|---|---|---|---|
| Genitourinary syndrome of menopause (vaginal or endometrial atrophy); most common cause | Light, intermittent spotting | Thin, pale vaginal mucosa; endometrial thickness often ≤ 4 mm | Vaginal estrogen, lubricants |
| Endometrial polyps | Irregular or episodic bleeding | Focal endometrial thickening; saline infusion sonohysterography helpful | Hysteroscopic removal |
| Endometrial hyperplasia (with or without atypia) | Variable bleeding | Endometrial thickness > 4 mm; biopsy is diagnostic | Progestins if atypia absent; hysterectomy if atypia present |
| Endometrial carcinoma | Postmenopausal bleeding as first symptom | Endometrial thickness often > 4 mm; biopsy is definitive | Gynecologic oncology referral |
| Cervical lesions | Postcoital bleeding | Visible friable lesion on examination | Papanicolaou or human papillomavirus test plus colposcopy |
| Nongynecologic mimics* | Bleeding from unclear source | Urinalysis, rectal examination, vulvar examination | Manage according to diagnosis |
*—Mimics include hematuria from urologic pathology, rectal bleeding from gastrointestinal sources, and vulvar bleeding from dermatologic conditions such as lichen sclerosus.
Information from references 1-7.
Read the full edition
Get immediate access, anytime, anywhere.
Choose a single edition, 1-year or 2-year full-access subscription.
Earn 4 CME credits for this edition.
